share_log

阳光诺和(688621.SH):在研产品重点包括复杂注射剂、多肽制剂、局部递送与透皮吸收药物、儿童用药、罕见病用药及其他特殊制剂等

Sunshine Novo (688621.SH): Product highlights under development include complex injections, peptide preparations, topical delivery and transdermal absorption drugs, pediatric drugs, rare disease drugs, and other special formulations

Gelonghui Finance ·  Nov 10, 2023 07:14

Gelonghui November 10th 丨Sunshine Novo (688621.SH)When surveyed by investors, it was stated that the company's generic drugs and innovative drugs are different R&D teams. The research fields they undertake within the company are different, and there are few team intersections. In terms of innovative drugs, the products being developed by the company are mainly used in the fields of analgesia, nephropathy and dialysis, tumor support, cardiovascular and cerebrovascular drugs, antibacterial drugs, etc.; in terms of improved new drugs, the company conducts technology research and development and industrial transformation research on drug delivery systems, focusing on research and development of long-acting microspherical preparations, controlled release preparations, etc.; in terms of generic drugs, products under development include complex injections, peptide preparations, partial delivery and transdermal absorption drugs, pediatric drugs, drugs for rare diseases, and other special preparations.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment